Literature DB >> 9305611

Induction of the differentiation of HL-60 promyelocytic leukemia cells by vitamin E and other antioxidants in combination with low levels of vitamin D3: possible relationship to NF-kappaB.

J A Sokoloski1, W F Hodnick, S T Mayne, C Cinquina, C S Kim, A C Sartorelli.   

Abstract

Epidemiological studies have provided evidence that diets rich in antioxidant nutrients may reduce the risk of cancer. To evaluate the possibility that dietary phytochemicals with antioxidant potential would create an environment capable of affecting the differentiation of HL-60 leukemia cells, we measured the effects of vitamin E and other dietary antioxidants on the differentiation produced by low levels of vitamin D3 and analogs thereof. Vitamin E succinate and other antioxidant compounds (ie butylated hydroxyanisole, beta-carotene and lipoic acid) used alone had no significant effect on the differentiation of HL-60 cells; however, these agents markedly increased the differentiation produced by vitamin D3. Previous studies from this laboratory have shown that a sequence-specific antisense phosphorothioate oligonucleotide to the Rel A subunit of NF-kappaB enhanced the differentiation of HL-60 cells produced by several inducing agents. Consistent with these observations, vitamin E succinate caused a marked reduction in the nuclear content of NF-kappaB both in the presence and absence of vitamin D3. These findings suggest that NF-kappaB may be a factor in regulating the differentiation of myeloid leukemia cells. The results also indicate that combinations of vitamin D3 and analogs thereof with dietary antioxidants may be useful in overcoming the differentiation block present in acute promyelocytic leukemia cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9305611     DOI: 10.1038/sj.leu.2400786

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  7 in total

1.  Curcumin induces differentiation of embryonic stem cells through possible modulation of nitric oxide-cyclic GMP pathway.

Authors:  Kalpana Mujoo; Lubov E Nikonoff; Vladislav G Sharin; Nathan S Bryan; Alexander Y Kots; Ferid Murad
Journal:  Protein Cell       Date:  2012-07-10       Impact factor: 14.870

2.  Cooperative antitumor effects of vitamin D3 derivatives and rosemary preparations in a mouse model of myeloid leukemia.

Authors:  Hagar Sharabani; Eugene Izumchenko; Qing Wang; Rita Kreinin; Michael Steiner; Zeev Barvish; Michael Kafka; Yoav Sharoni; Joseph Levy; Milan Uskokovic; George P Studzinski; Michael Danilenko
Journal:  Int J Cancer       Date:  2006-06-15       Impact factor: 7.396

3.  Cellular redox state and activating protein-1 are involved in ascorbate effect on calcitriol-induced differentiation.

Authors:  G López-Lluch; M V Blázquez; R Pérez-Vicente; A Macho; M I Burón; F J Alcaín; E Muñoz; P Navas
Journal:  Protoplasma       Date:  2001       Impact factor: 3.356

4.  Enhancement of 1 alpha,25-dihydroxyvitamin D(3)-induced differentiation of human leukaemia HL-60 cells into monocytes by parthenolide via inhibition of NF-kappa B activity.

Authors:  S N Kang; S H Kim; S W Chung; M H Lee; H J Kim; T S Kim
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

5.  Kuromoji (Lindera umbellata) essential oil-induced apoptosis and differentiation in human leukemia HL-60 cells.

Authors:  Hayato Maeda; Mao Yamazaki; Yohtaro Katagata
Journal:  Exp Ther Med       Date:  2011-09-27       Impact factor: 2.447

6.  Differential enhancement of leukaemia cell differentiation without elevation of intracellular calcium by plant-derived sesquiterpene lactone compounds.

Authors:  S H Kim; M Danilenko; T S Kim
Journal:  Br J Pharmacol       Date:  2008-08-25       Impact factor: 8.739

7.  Cell-Type-Specific Effects of Silibinin on Vitamin D-Induced Differentiation of Acute Myeloid Leukemia Cells Are Associated with Differential Modulation of RXRα Levels.

Authors:  Rina Wassermann; Victoria Novik; Michael Danilenko
Journal:  Leuk Res Treatment       Date:  2012-05-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.